nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—CHRM3—nephrolithiasis	0.827	1	CbGaD
Atropine—Oral lesion—Hydrochlorothiazide—nephrolithiasis	0.0115	0.129	CcSEcCtD
Atropine—CHRM3—ureter—nephrolithiasis	0.0086	0.683	CbGeAlD
Atropine—CHRM4—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00814	0.127	CbGpPWpGaD
Atropine—CHRM5—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00779	0.121	CbGpPWpGaD
Atropine—Oral disorder—Hydrochlorothiazide—nephrolithiasis	0.00658	0.0742	CcSEcCtD
Atropine—CHRM1—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00549	0.0854	CbGpPWpGaD
Atropine—CHRM2—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00542	0.0843	CbGpPWpGaD
Atropine—Arrhythmia supraventricular—Hydrochlorothiazide—nephrolithiasis	0.00429	0.0483	CcSEcCtD
Atropine—Intraocular pressure increased—Hydrochlorothiazide—nephrolithiasis	0.00378	0.0426	CcSEcCtD
Atropine—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.00242	0.0272	CcSEcCtD
Atropine—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00225	0.0253	CcSEcCtD
Atropine—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00217	0.0245	CcSEcCtD
Atropine—CYP1A2—urine—nephrolithiasis	0.00212	0.169	CbGeAlD
Atropine—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.00212	0.0239	CcSEcCtD
Atropine—Stinging—Hydrochlorothiazide—nephrolithiasis	0.00205	0.0231	CcSEcCtD
Atropine—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00184	0.0207	CcSEcCtD
Atropine—CHRM4—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0018	0.028	CbGpPWpGaD
Atropine—CHRM5—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00172	0.0268	CbGpPWpGaD
Atropine—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00166	0.0187	CcSEcCtD
Atropine—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00157	0.0177	CcSEcCtD
Atropine—Methylscopolamine bromide—CHRM3—nephrolithiasis	0.00152	0.204	CrCbGaD
Atropine—CHRM4—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00151	0.0235	CbGpPWpGaD
Atropine—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00148	0.0167	CcSEcCtD
Atropine—CHRM5—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00145	0.0225	CbGpPWpGaD
Atropine—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00137	0.0154	CcSEcCtD
Atropine—Cyclopentolate—CHRM3—nephrolithiasis	0.00133	0.179	CrCbGaD
Atropine—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00133	0.0149	CcSEcCtD
Atropine—Scopolamine—CHRM3—nephrolithiasis	0.00129	0.173	CrCbGaD
Atropine—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00127	0.0144	CcSEcCtD
Atropine—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00127	0.0143	CcSEcCtD
Atropine—CHRM1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00121	0.0189	CbGpPWpGaD
Atropine—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00121	0.0137	CcSEcCtD
Atropine—CHRM2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0012	0.0186	CbGpPWpGaD
Atropine—Hyoscyamine—CHRM3—nephrolithiasis	0.00119	0.159	CrCbGaD
Atropine—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00114	0.0128	CcSEcCtD
Atropine—Homatropine Methylbromide—CHRM3—nephrolithiasis	0.00112	0.15	CrCbGaD
Atropine—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00111	0.0125	CcSEcCtD
Atropine—CHRM4—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0011	0.0172	CbGpPWpGaD
Atropine—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.0011	0.0124	CcSEcCtD
Atropine—CHRM5—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00106	0.0164	CbGpPWpGaD
Atropine—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00105	0.0118	CcSEcCtD
Atropine—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00104	0.0118	CcSEcCtD
Atropine—CHRM1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00102	0.0159	CbGpPWpGaD
Atropine—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00102	0.0115	CcSEcCtD
Atropine—CHRM2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00101	0.0157	CbGpPWpGaD
Atropine—Ipratropium bromide—CHRM3—nephrolithiasis	0.001	0.134	CrCbGaD
Atropine—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.000976	0.011	CcSEcCtD
Atropine—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.000961	0.0108	CcSEcCtD
Atropine—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.000941	0.0106	CcSEcCtD
Atropine—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.000917	0.0103	CcSEcCtD
Atropine—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.000912	0.0103	CcSEcCtD
Atropine—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.000904	0.0102	CcSEcCtD
Atropine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.000892	0.01	CcSEcCtD
Atropine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00085	0.00958	CcSEcCtD
Atropine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000775	0.00873	CcSEcCtD
Atropine—CHRM4—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000766	0.0119	CbGpPWpGaD
Atropine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000746	0.00841	CcSEcCtD
Atropine—CHRM1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000743	0.0116	CbGpPWpGaD
Atropine—CHRM3—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000741	0.0115	CbGpPWpGaD
Atropine—CHRM2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000734	0.0114	CbGpPWpGaD
Atropine—Erythema—Hydrochlorothiazide—nephrolithiasis	0.000727	0.00819	CcSEcCtD
Atropine—Tension—Hydrochlorothiazide—nephrolithiasis	0.000713	0.00804	CcSEcCtD
Atropine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000712	0.00802	CcSEcCtD
Atropine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.000706	0.00796	CcSEcCtD
Atropine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.000685	0.00772	CcSEcCtD
Atropine—CHRM3—renal system—nephrolithiasis	0.000684	0.0543	CbGeAlD
Atropine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.000668	0.00753	CcSEcCtD
Atropine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.000664	0.00748	CcSEcCtD
Atropine—CHRM3—kidney—nephrolithiasis	0.000661	0.0525	CbGeAlD
Atropine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.000653	0.00736	CcSEcCtD
Atropine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000652	0.00735	CcSEcCtD
Atropine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.000642	0.00724	CcSEcCtD
Atropine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000639	0.0072	CcSEcCtD
Atropine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000619	0.00697	CcSEcCtD
Atropine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.000617	0.00695	CcSEcCtD
Atropine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000605	0.00682	CcSEcCtD
Atropine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000598	0.00674	CcSEcCtD
Atropine—CHRM5—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000595	0.00926	CbGpPWpGaD
Atropine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000593	0.00668	CcSEcCtD
Atropine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000593	0.00668	CcSEcCtD
Atropine—Shock—Hydrochlorothiazide—nephrolithiasis	0.000584	0.00658	CcSEcCtD
Atropine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.000579	0.00652	CcSEcCtD
Atropine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000574	0.00646	CcSEcCtD
Atropine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000554	0.00625	CcSEcCtD
Atropine—CHRM4—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000538	0.00838	CbGpPWpGaD
Atropine—CHRM4—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000538	0.00838	CbGpPWpGaD
Atropine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000537	0.00605	CcSEcCtD
Atropine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000532	0.00828	CbGpPWpGaD
Atropine—CHRM2—GPCRs, Other—CHRM3—nephrolithiasis	0.000532	0.00828	CbGpPWpGaD
Atropine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000529	0.00596	CcSEcCtD
Atropine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000527	0.00594	CcSEcCtD
Atropine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000522	0.00588	CcSEcCtD
Atropine—CYP1A2—renal system—nephrolithiasis	0.000519	0.0412	CbGeAlD
Atropine—CHRM5—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000515	0.00803	CbGpPWpGaD
Atropine—CHRM5—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000515	0.00803	CbGpPWpGaD
Atropine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000512	0.00576	CcSEcCtD
Atropine—CHRM2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00051	0.00793	CbGpPWpGaD
Atropine—Pain—Hydrochlorothiazide—nephrolithiasis	0.000507	0.00572	CcSEcCtD
Atropine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000507	0.00572	CcSEcCtD
Atropine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000489	0.00551	CcSEcCtD
Atropine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000485	0.00547	CcSEcCtD
Atropine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000471	0.00531	CcSEcCtD
Atropine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000469	0.00528	CcSEcCtD
Atropine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000469	0.00528	CcSEcCtD
Atropine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000437	0.00492	CcSEcCtD
Atropine—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.000433	0.00675	CbGpPWpGaD
Atropine—CHRM5—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00043	0.00669	CbGpPWpGaD
Atropine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000426	0.0048	CcSEcCtD
Atropine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00042	0.00473	CcSEcCtD
Atropine—CHRM1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000419	0.00652	CbGpPWpGaD
Atropine—CHRM3—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000417	0.0065	CbGpPWpGaD
Atropine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000406	0.00457	CcSEcCtD
Atropine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000392	0.00442	CcSEcCtD
Atropine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000384	0.00599	CbGpPWpGaD
Atropine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000377	0.00425	CcSEcCtD
Atropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000374	0.00583	CbGpPWpGaD
Atropine—Rash—Hydrochlorothiazide—nephrolithiasis	0.000374	0.00421	CcSEcCtD
Atropine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000374	0.00421	CcSEcCtD
Atropine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000373	0.00581	CbGpPWpGaD
Atropine—Headache—Hydrochlorothiazide—nephrolithiasis	0.000372	0.00419	CcSEcCtD
Atropine—CHRM1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000363	0.00565	CbGpPWpGaD
Atropine—CHRM1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000363	0.00565	CbGpPWpGaD
Atropine—CHRM2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000358	0.00558	CbGpPWpGaD
Atropine—CHRM2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000358	0.00558	CbGpPWpGaD
Atropine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000352	0.00397	CcSEcCtD
Atropine—CHRM4—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000347	0.0054	CbGpPWpGaD
Atropine—CHRM5—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000332	0.00517	CbGpPWpGaD
Atropine—CHRM1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000303	0.00471	CbGpPWpGaD
Atropine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000297	0.00463	CbGpPWpGaD
Atropine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000285	0.00443	CbGpPWpGaD
Atropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000271	0.00421	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—RGS14—nephrolithiasis	0.000262	0.00408	CbGpPWpGaD
Atropine—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.000254	0.00395	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—RGS14—nephrolithiasis	0.000251	0.00391	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—RGS14—nephrolithiasis	0.000238	0.0037	CbGpPWpGaD
Atropine—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000234	0.00364	CbGpPWpGaD
Atropine—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000231	0.0036	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—RGS14—nephrolithiasis	0.000228	0.00355	CbGpPWpGaD
Atropine—CHRM4—GPCR ligand binding—CHRM3—nephrolithiasis	0.000226	0.00352	CbGpPWpGaD
Atropine—CHRM5—GPCR ligand binding—CHRM3—nephrolithiasis	0.000217	0.00338	CbGpPWpGaD
Atropine—CHRM4—GPCR ligand binding—PTH—nephrolithiasis	0.000207	0.00322	CbGpPWpGaD
Atropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0002	0.00312	CbGpPWpGaD
Atropine—CHRM5—GPCR ligand binding—PTH—nephrolithiasis	0.000198	0.00309	CbGpPWpGaD
Atropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000198	0.00308	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—DGKH—nephrolithiasis	0.000177	0.00275	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000177	0.00275	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—RGS14—nephrolithiasis	0.000176	0.00274	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000174	0.00271	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—DGKH—nephrolithiasis	0.000169	0.00264	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—ADCY10—nephrolithiasis	0.000165	0.00257	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—DGKH—nephrolithiasis	0.000161	0.0025	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.00016	0.0025	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—RGS14—nephrolithiasis	0.00016	0.00249	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.000158	0.00247	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—ADCY10—nephrolithiasis	0.000158	0.00246	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—DGKH—nephrolithiasis	0.000154	0.0024	CbGpPWpGaD
Atropine—CHRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000153	0.00238	CbGpPWpGaD
Atropine—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000151	0.00235	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—RGS14—nephrolithiasis	0.000141	0.00219	CbGpPWpGaD
Atropine—CHRM1—GPCR ligand binding—PTH—nephrolithiasis	0.00014	0.00217	CbGpPWpGaD
Atropine—CHRM3—GPCR ligand binding—PTH—nephrolithiasis	0.000139	0.00217	CbGpPWpGaD
Atropine—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	0.000138	0.00215	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—RGS14—nephrolithiasis	0.000135	0.0021	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000128	0.00199	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000123	0.00191	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000119	0.00186	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—DGKH—nephrolithiasis	0.000119	0.00185	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000118	0.00183	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—PTH—nephrolithiasis	0.000117	0.00182	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—CHRM3—nephrolithiasis	0.000116	0.00181	CbGpPWpGaD
Atropine—CHRM3—Metabolism—GRHPR—nephrolithiasis	0.000113	0.00176	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—PTH—nephrolithiasis	0.000112	0.00174	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	0.000111	0.00173	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—CHRM3—nephrolithiasis	0.000111	0.00173	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ADCY10—nephrolithiasis	0.000111	0.00173	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	0.00011	0.00171	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	0.000108	0.00169	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	0.000108	0.00168	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	0.000107	0.00167	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—PTH—nephrolithiasis	0.000106	0.00165	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—PTH—nephrolithiasis	0.000102	0.00158	CbGpPWpGaD
Atropine—CHRM3—Metabolism—AGXT—nephrolithiasis	0.000101	0.00157	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—ATP6V0A4—nephrolithiasis	9.49e-05	0.00148	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—DGKH—nephrolithiasis	9.49e-05	0.00148	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	9.47e-05	0.00148	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	9.44e-05	0.00147	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	9.35e-05	0.00146	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—ATP6V0A4—nephrolithiasis	9.09e-05	0.00142	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—DGKH—nephrolithiasis	9.09e-05	0.00142	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	8.63e-05	0.00134	CbGpPWpGaD
Atropine—CHRM3—Metabolism—SLC26A1—nephrolithiasis	8.56e-05	0.00133	CbGpPWpGaD
Atropine—CHRM3—Metabolism—APRT—nephrolithiasis	8.56e-05	0.00133	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	8.51e-05	0.00133	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	7.89e-05	0.00123	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	7.86e-05	0.00122	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	7.83e-05	0.00122	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	7.79e-05	0.00121	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	7.73e-05	0.0012	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	7.16e-05	0.00112	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	7.14e-05	0.00111	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	7.07e-05	0.0011	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CHRM3—nephrolithiasis	6.86e-05	0.00107	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CHRM3—nephrolithiasis	6.57e-05	0.00102	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	6.4e-05	0.000996	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	6.4e-05	0.000996	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	6.38e-05	0.000993	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	6.38e-05	0.000993	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	6.32e-05	0.000984	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	6.32e-05	0.000984	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PTH—nephrolithiasis	6.28e-05	0.000977	CbGpPWpGaD
Atropine—CHRM3—Metabolism—AQP1—nephrolithiasis	6.1e-05	0.00095	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PTH—nephrolithiasis	6.01e-05	0.000936	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GRHPR—nephrolithiasis	5.72e-05	0.000891	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—AGXT—nephrolithiasis	5.1e-05	0.000794	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	4.63e-05	0.00072	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	4.57e-05	0.000711	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—APRT—nephrolithiasis	4.34e-05	0.000675	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	4.34e-05	0.000675	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PTH—nephrolithiasis	4.23e-05	0.000659	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PTH—nephrolithiasis	4.22e-05	0.000657	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PTH—nephrolithiasis	4.18e-05	0.00065	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—SPP1—nephrolithiasis	3.15e-05	0.000491	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—AQP1—nephrolithiasis	3.09e-05	0.000481	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—SPP1—nephrolithiasis	3.02e-05	0.00047	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CHRM3—nephrolithiasis	2.79e-05	0.000435	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	2.12e-05	0.000331	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	2.12e-05	0.00033	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	2.1e-05	0.000327	CbGpPWpGaD
